Sign inJoin waitlistJoin the waitlist

KR

Katherine Ruffner

Hematology & Oncology

Credentials: ·

Research

Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study
The Lancet Oncology · 2012 · 1,019 citations
Experimental therapy of human glioma by means of a genetically engineered virus mutant
Science · 1991 · 835 citations
Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study
The Lancet Oncology · 2013 · 567 citations

Adetola Kassim
3 papers
DM
Dana Matthews
3 papers
DM
David Morgan
3 papers
FS
Friedrich Schuening
3 papers
JG
John Greer
3 papers
Madan Jagasia
3 papers
BE
Brian Engelhardt
2 papers · 2 as a fellow
Irwin Bernstein
2 papers
Paul Martin
2 papers
SG
Stacey Goodman
2 papers
WC
Wichai Chinratanalab
2 papers
Ajay Gopal
1 paper